Polymorphism of the complement 5 gene is associated with large artery atherosclerosis stroke in Chinese patients

被引:0
作者
Wu, Hui [1 ]
Weng, Yingfeng [1 ]
Zheng, Lan [1 ]
Li, Huanyin [1 ]
Gong, Qi [1 ]
Fu, Yi [2 ]
Zhao, Jing [1 ]
机构
[1] Minhang Dist Cent Hosp, Dept Neurol, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China
基金
中国国家自然科学基金;
关键词
genes; stroke; ACUTE ISCHEMIC-STROKE; DISEASE; RISK; RELIABILITY; ACTIVATION; OUTCOMES; HUMANS; SCALE; MICE;
D O I
10.1590/0004-282X20160139
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The complement system has been confirmed to play an increasingly important role in ischemic stroke (IS). This study aimed to determine whether the single-nucleotide polymorphism of the complement 5 (C5) gene independently influences the occurrence, severity, and long-term outcome of IS in Chinese patients. Methods: C5 rs17611 genetic variants were investigated in 494 IS patients and 330 control individuals. Ischemic stroke was classified into subtypes and patients were assessed 90 days post-stroke with the modified Rankin Scale to determine stroke outcome. Results: The presence of C5 polymorphism was associated with the incidence of large artery atherosclerosis (LAA)-subtype IS (n = 2 00; p = 0.031), which even persisted after adjustment for covariates (OR = 1.518; 95% CI = 1.093-2.018; p = 0.013). However, no association was found between genotypes and the severity and outcome of stroke (p = 0.978; p = 0.296). Conclusions: The C5 polymorphism might contribute to the risk of LAA-subtype IS independently of other known risk predictors.
引用
收藏
页码:881 / 886
页数:6
相关论文
共 23 条
  • [11] Complement component C5a Promotes Expression of IL-22 and IL-17 from Human T cells and its Implication in Age-related Macular Degeneration
    Liu, Baoying
    Wei, Lai
    Meyerle, Catherine
    Tuo, Jingsheng
    Sen, H. Nida
    Li, Zhiyu
    Chakrabarty, Sagarika
    Agron, Elvira
    Chan, Chi-Chao
    Klein, Michael L.
    Chew, Emily
    Ferris, Frederick
    Nussenblatt, Robert B.
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2011, 9
  • [12] Modified national institutes of health stroke scale for use in stroke clinical trials - Prospective reliability and validity
    Meyer, BC
    Hemmen, TM
    Jackson, CM
    Lyden, PD
    [J]. STROKE, 2002, 33 (05) : 1261 - 1266
  • [13] Mocco J, 2006, NEUROSURGERY, V59, P28, DOI 10.1227/01.neu.0000243280.75920.f4
  • [14] The role of complement activation in atherosclerosis
    Niculescu, F
    Rus, H
    [J]. IMMUNOLOGIC RESEARCH, 2004, 30 (01) : 73 - 80
  • [15] Reliability of Structured Modified Rankin Scale Assessment
    Quinn, Terence J.
    McArthur, Kate
    Dawson, Jesse
    Walters, Matthew R.
    Lees, Kennedy R.
    [J]. STROKE, 2010, 41 (12) : E602 - E602
  • [16] Mechanisms of disease - Atherosclerosis - An inflammatory disease
    Ross, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (02) : 115 - 126
  • [17] COMPLEMENT RECEPTORS AND REGULATORY PROTEINS IN HUMAN ATHEROSCLEROTIC LESIONS
    SEIFERT, PS
    HANSSON, GK
    [J]. ARTERIOSCLEROSIS, 1989, 9 (06): : 802 - 811
  • [18] Plasma C3 and C3a Levels in Cryptogenic and Large-Vessel Disease Stroke: Associations with Outcome
    Stokowska, Anna
    Olsson, Sandra
    Holmegaard, Lukas
    Jood, Katarina
    Blomstrand, Christian
    Jern, Christina
    Pekna, Marcela
    [J]. CEREBROVASCULAR DISEASES, 2011, 32 (02) : 114 - 122
  • [19] Role of complement in the pathomechanism of atherosclerotic vascular diseases
    Szeplaki, Gabor
    Varga, Lilian
    Fust, George
    Prohaszka, Zoltan
    [J]. MOLECULAR IMMUNOLOGY, 2009, 46 (14) : 2784 - 2793
  • [20] Strong complement activation after acute ischemic stroke is associated with unfavorable outcomes
    Szeplaki, Gabor
    Szegedi, Robert
    Hirschberg, Kristof
    Gombos, Timea
    Varga, Lilian
    Karadi, Istvan
    Entz, Laszlo
    Szeplaki, Zoltan
    Garred, Peter
    Prohaszka, Zoltan
    Fust, George
    [J]. ATHEROSCLEROSIS, 2009, 204 (01) : 315 - 320